医学
转移性乳腺癌
曲妥珠单抗
富维斯特朗
内科学
肿瘤科
临床研究阶段
乳腺癌
癌症
临床试验
毒性
转移
癌症研究
紫杉醇
化疗
疾病
作者
Komal Jhaveri,Loi Sherene,Erika Hamilton,Peter Schmid,CK Anders,L. Testa,Hans Wildiers,Ling-Ming Tseng,Yen-Shen Lu,Yeon Hee Park,Seock-Ah Im,Shin-Cheh Chen,Robyn R. Young,Caron Lloyd,Magdalena Wrona,Cuihong Zhang,Danielle Carroll,Fabrice Andre
标识
DOI：10.1158/1078-0432.ccr-25-0874
摘要
Safety results were generally consistent with known individual profiles for T-DXd and combination drugs. T-DXd plus capecitabine, capivasertib, anastrozole, or fulvestrant demonstrated preliminary clinical activity in patients with HER2-low mBC.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
ssfg
Rocky
YangShu
Kao
Copyright
自由飞翔
愉快的真
22336
369ninja
英俊乐珍
韩笑
Nole
嘻嘻哈哈
OK
ting
vict
GingerF
行走的荷尔蒙
初景
渡人舟
皖公网安备34019202002308
